NOAH website
Compendium home page
Introduction
Presentation
Uses
Dosage and administration
Contra-indications, warnings, etc
Pharmaceutical precautions
Legal category
Packaging Quantities
Further information
Marketing authorisation number
You are here:
Introduction
> Presentation
Vanguard CPV: Presentation
Vanguard CPV
Presentation
A solution for injection, each 1ml dose containing live attenuated canine parvovirus, NL-35-D strain, low passage ≥ 10
7.0
CCID
50
.
Date updated: 9 June 2006
Powered by the Librios Semantic Environment
Vanguard CPV: Presentation
Date updated: 9 June 2006